{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:54:00Z","timestamp":1781859240929,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.mcna.2025.11.002","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:29:25Z","timestamp":1766406565000},"page":"501-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inpatient Diabetes Management in Special Populations (Elderly, Cystic Fibrosis, Pregnancy, Chronic Kidney Disease, and Liver Dysfunction)"],"prefix":"10.1016","volume":"110","author":[{"given":"Shivani","family":"Seth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeni","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.diabres.2013.11.003","article-title":"Global estimates of the prevalence of hyperglycaemia in pregnancy","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2025.11.002_bib2","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.mcna.2025.11.002_bib3","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1210\/clinem\/dgac464","article-title":"Diabetic ketoacidosis in pregnancy: clinical risk factors, presentation, and outcomes","volume":"107","author":"Dhanasekaran","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.mcna.2025.11.002_bib4","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.2337\/dc19-0859","article-title":"Increased insulin requirements in twin pregnancy in type 1 diabetes","volume":"42","author":"De F\u00f8nss","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237571","article-title":"Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes","volume":"15","author":"Wahabi","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.002_bib6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2337\/diacare.27.5.1200","article-title":"HbA1c levels are significantly lower in early and late pregnancy","volume":"27","author":"Nielsen","year":"2004","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2025.11.002_bib7","first-page":"S306","article-title":"215. Management of diabetes in pregnancy: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diaspect.29.2.92","article-title":"Insulin use in pregnancy: an update","volume":"29","author":"Blum","year":"2016","journal-title":"Diabetes Spectr"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/dc13-1348","article-title":"Peripartum management of glycemia in women with type 1 diabetes","volume":"37","author":"Achong","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2025.11.002_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11892-013-0457-x","article-title":"Inpatient management of women with gestational and pregestational diabetes in pregnancy","volume":"14","author":"Garrison","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.mcna.2025.11.002_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11892-018-1045-x","article-title":"Inpatient glycemic management of the pregnant patient","volume":"18","author":"Yeh","year":"2018","journal-title":"Curr Diabetes Rep"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.002_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00003081-199403000-00008","article-title":"Diabetic ketoacidosis in pregnancy: etiology, pathophysiology, and management","volume":"37","author":"Hagay","year":"1994","journal-title":"Clin Obstet Gynecol"},{"issue":"10 Suppl","key":"10.1016\/j.mcna.2025.11.002_bib13","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1097\/01.CCM.0000183164.69315.13","article-title":"Diabetic ketoacidosis in pregnancy","volume":"33","author":"Carroll","year":"2005","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/1947-2714.127744","article-title":"Glycemic management after antenatal corticosteroid therapy","volume":"6","author":"Kalra","year":"2014","journal-title":"N Am J Med Sci"},{"issue":"9","key":"10.1016\/j.mcna.2025.11.002_bib15","first-page":"565","article-title":"Efecto de la betametasona en la glucemia de diab\u00e9ticas embarazadas en riesgo de nacimiento pret\u00e9rmino [Effect of betamethasone in blood glucose levels in pregnant diabetic women at risk of preterm birth]","volume":"79","author":"Ram\u00edrez-Torres","year":"2011","journal-title":"Ginecolog Obstet Mex"},{"issue":"9","key":"10.1016\/j.mcna.2025.11.002_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1034\/j.1600-0412.2002.810906.x","article-title":"Insulin dose during glucocorticoid treatment for fetal lung maturation in diabetic pregnancy: test of an algorithm [correction of analgoritm]","volume":"81","author":"Mathiesen","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"12","key":"10.1016\/j.mcna.2025.11.002_bib17","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and kidney disease: improving global outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.002_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00304849","article-title":"The renal metabolism of insulin","volume":"27","author":"Rabkin","year":"1984","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.002_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.jrn.2008.11.012","article-title":"Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus","volume":"19","author":"Kalantar-Zadeh","year":"2009","journal-title":"J Ren Nutr"},{"issue":"11","key":"10.1016\/j.mcna.2025.11.002_bib20","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1210\/jc.2019-00286","article-title":"Disturbances in insulin-glucose metabolism in patients with advanced renal disease with and without diabetes","volume":"104","author":"Rahhal","year":"2019","journal-title":"J Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.002_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1210\/endrev\/bnaa017","article-title":"Glycemic monitoring and management in advanced chronic kidney disease","volume":"41","author":"Galindo","year":"2020","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.002_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1932296817747620","article-title":"Hypoglycemia in hospitalized hemodialysis patients with diabetes: an observational study","volume":"12","author":"Gianchandani","year":"2018","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1464-5491.2003.01025.x","article-title":"Decreased insulin requirement in relation to GFR in nephropathic type 1 and insulin-treated type 2 diabetic patients","volume":"20","author":"Biesenbach","year":"2003","journal-title":"Diabet Med : a journal of the British Diabetic Association"},{"issue":"10","key":"10.1016\/j.mcna.2025.11.002_bib24","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2337\/dc12-0578","article-title":"A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency","volume":"35","author":"Baldwin","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.002_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/sdi.12368","article-title":"Antidiabetic therapy in end-stage renal disease","volume":"28","author":"Boyle","year":"2015","journal-title":"Semin Dial"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.002_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jorc.12266","article-title":"Managing care for people with diabetes undergoing dialysis","volume":"45","author":"Gregory","year":"2019","journal-title":"J Ren Care"},{"issue":"7","key":"10.1016\/j.mcna.2025.11.002_bib27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2337\/dc09-2176","article-title":"Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis","volume":"33","author":"Sobngwi","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2025.11.002_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6923543","article-title":"Effectiveness of dose adjustment of insulin in type 2 diabetes among hemodialysis patients with end-stage renal disease: a randomized crossover study","volume":"2019","author":"Singhsakul","year":"2019","journal-title":"J Diabetes Res"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/phar.2659","article-title":"Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis","volume":"42","author":"Blaine","year":"2022","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.002_bib30","doi-asserted-by":"crossref","first-page":"E132","DOI":"10.25011\/cim.v35i3.16589","article-title":"Subcutaneous versus intraperitoneal insulin for patients with diabetes mellitus on continuous ambulatory peritoneal dialysis: meta-analysis of non-randomized clinical trials","volume":"35","author":"Almalki","year":"2012","journal-title":"Clin Invest Med"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.002_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP161471.RA","article-title":"Pathophysiology and management of hypoglycemia in end-stage renal disease patients: a review","volume":"23","author":"Gianchandani","year":"2017","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/dme.13676","article-title":"Management of adults with diabetes on the haemodialysis unit: summary of guidance from the Joint British Diabetes Societies and the Renal Association","volume":"35","author":"Frankel","year":"2018","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib33","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2021.16","article-title":"Diabetic ketoacidosis in patients with end-stage kidney disease: a review","volume":"36","author":"Al Sadhan","year":"2021","journal-title":"Oman Med J"},{"issue":"12","key":"10.1016\/j.mcna.2025.11.002_bib34","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1007\/s11606-012-2132-3","article-title":"Symptom burden of adults with type 2 diabetes across the disease course: diabetes & aging study","volume":"27","author":"Sudore","year":"2012","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib35","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc10-2424","article-title":"Correlates of quality of life in older adults with diabetes: the diabetes & aging study","volume":"34","author":"Laiteerapong","year":"2011","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2025.11.002_bib36","first-page":"S244","article-title":"13. Older adults: standards of care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.mcna.2025.11.002_bib37","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.163.15.1825","article-title":"Hypoglycemia as a predictor of mortality in hospitalized elderly patients","volume":"163","author":"Kagansky","year":"2003","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.002_bib38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/193229681200600505","article-title":"Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes","volume":"6","author":"Farrokhi","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib39","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2337\/dc09-0114","article-title":"Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes","volume":"32","author":"Bremer","year":"2009","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib40","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc12-1988","article-title":"Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.mcna.2025.11.002_bib42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2337\/dc16-0989","article-title":"Management of inpatient hyperglycemia and diabetes in older adults","volume":"40","author":"Umpierrez","year":"2017","journal-title":"Diabetes Care"},{"issue":"S48","key":"10.1016\/j.mcna.2025.11.002_bib43","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1002\/ppul.23762","article-title":"CF-related diabetes: containing the metabolic miscreant of cystic fibrosis","volume":"52","author":"Moheet","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 27","key":"10.1016\/j.mcna.2025.11.002_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/pedi.12732","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents","volume":"19","author":"Moran","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"10.1016\/j.mcna.2025.11.002_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcf.2006.03.009","article-title":"Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis","volume":"6","author":"Brennan","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.mcna.2025.11.002_bib46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jcf.2017.01.018","article-title":"Association between glucose intolerance and bacterial colonisation in an adult population with cystic fibrosis, emergence of Stenotrophomonas maltophilia","volume":"16","author":"Dubois","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.mcna.2025.11.002_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/eje.0.1490053","article-title":"Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia","volume":"149","author":"Lombardo","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98240","article-title":"Cystic fibrosis\u2013related diabetes is caused by islet loss and inflammation","volume":"3","author":"Hart","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.mcna.2025.11.002_bib49","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.mcna.2025.11.002_bib50","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis\u2013related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.mcna.2025.11.002_bib51","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1651-2227.1994.tb13156.x","article-title":"Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections","volume":"83","author":"Lanng","year":"1994","journal-title":"Acta Paediatr"},{"issue":"7","key":"10.1016\/j.mcna.2025.11.002_bib52","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1515\/jpem-2019-0484","article-title":"Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment","volume":"33","author":"Alves","year":"2020","journal-title":"J Pediatr Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.mcna.2025.11.002_bib53","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/193229681200600507","article-title":"Cystic fibrosis-related diabetes in adults: inpatient management of 121 patients during 410 admissions","volume":"6","author":"Rasouli","year":"2012","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.mcna.2025.11.002_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3157","article-title":"Prevalence of diabetes in liver cirrhosis: a systematic review and meta-analysis","volume":"35","author":"Lee","year":"2019","journal-title":"Diabetes\/metabolism research and reviews"},{"issue":"7","key":"10.1016\/j.mcna.2025.11.002_bib55","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/liv.13115","article-title":"Diabetes mellitus in patients with cirrhosis: clinical implications and management","volume":"36","author":"Elkrief","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.mcna.2025.11.002_bib56","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/HEP.0000000000000263","article-title":"Diabetes and cirrhosis: current concepts on diagnosis and management","volume":"77","author":"Castera","year":"2023","journal-title":"Hepatology"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525001610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525001610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:20:38Z","timestamp":1781857238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712525001610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0025712525001610"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2025.11.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inpatient Diabetes Management in Special Populations (Elderly, Cystic Fibrosis, Pregnancy, Chronic Kidney Disease, and Liver Dysfunction)","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2025.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}